Successful treatment with anti-tumor necrosis factor alpha for     reactive small-bowel amyloidosis.
Division of Gastroenterology, Department of Internal medicine, School of Medicine, Kyung Hee University, Seoul, Korea. cklee92@paran.com
C K
CK
Lee
J Y
JY
Park
J-J
JJ
Shim
J Y
JY
Jang
D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D004378:Duodenal Diseases / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007077:Ileal Diseases / Q000175:diagnosis / Q000188:drug therapy; D000069285:Infliximab; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab